170 related articles for article (PubMed ID: 23254773)
1. cAMP-binding site of PKA as a molecular target of bisabolangelone against melanocyte-specific hyperpigmented disorder.
Roh E; Yun CY; Young Yun J; Park D; Doo Kim N; Yeon Hwang B; Jung SH; Park SK; Kim YB; Han SB; Kim Y
J Invest Dermatol; 2013 Apr; 133(4):1072-9. PubMed ID: 23254773
[TBL] [Abstract][Full Text] [Related]
2. cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.
Shin H; Hong SD; Roh E; Jung SH; Cho WJ; Park SH; Yoon DY; Ko SM; Hwang BY; Hong JT; Heo TY; Han SB; Kim Y
Br J Pharmacol; 2015 Jul; 172(13):3434-45. PubMed ID: 25766244
[TBL] [Abstract][Full Text] [Related]
3. α-Viniferin Improves Facial Hyperpigmentation via Accelerating Feedback Termination of cAMP/PKA-Signaled Phosphorylation Circuit in Facultative Melanogenesis.
Yun CY; Mi Ko S; Pyo Choi Y; Kim BJ; Lee J; Mun Kim J; Kim JY; Song JY; Kim SH; Hwang BY; Tae Hong J; Han SB; Kim Y
Theranostics; 2018; 8(7):2031-2043. PubMed ID: 29556371
[No Abstract] [Full Text] [Related]
4. Hypopigmenting activity of bisabolangelone isolated from Angelica koreana Maxim. in α-melanocyte stimulating hormone-activated B16 or melan-a cells.
Roh E; Yun CY; Lee JW; Lee C; Hwang BY; Oh ST; Jung SH; Han SB; Kim Y
Planta Med; 2011 Feb; 77(3):248-51. PubMed ID: 20814852
[TBL] [Abstract][Full Text] [Related]
5. A novel adamantyl benzylbenzamide derivative, AP736, suppresses melanogenesis through the inhibition of cAMP-PKA-CREB-activated microphthalmia-associated transcription factor and tyrosinase expression.
Lee CS; Jang WH; Park M; Jung K; Baek HS; Joo YH; Park YH; Lim KM
Exp Dermatol; 2013 Nov; 22(11):762-4. PubMed ID: 24107097
[TBL] [Abstract][Full Text] [Related]
6. Effect of saucerneol D on melanin production in cAMP-elevated melanocytes.
Yun JY; Roh E; Son JK; Lee SH; Seo CS; Hwang BY; Han SB; Kim Y
Arch Pharm Res; 2011 Aug; 34(8):1339-45. PubMed ID: 21910056
[TBL] [Abstract][Full Text] [Related]
7. Targeting phosphorylation circuits on CREB and CRTCs as the strategy to prevent acquired skin hyperpigmentation.
Kim SH; Na C; Yun CY; Kim JG; Baek ST; An HJ; Lee JD; Lee SW; Jung JK; Hwang BY; Han SB; Kim Y
Int J Biol Sci; 2024; 20(1):312-330. PubMed ID: 38164184
[No Abstract] [Full Text] [Related]
8. Sargaquinoic acid ameliorates hyperpigmentation through cAMP and ERK-mediated downregulation of MITF in α-MSH-stimulated B16F10 cells.
Azam MS; Kwon M; Choi J; Kim HR
Biomed Pharmacother; 2018 Aug; 104():582-589. PubMed ID: 29803170
[TBL] [Abstract][Full Text] [Related]
9. Interruption of p38
Kim SH; Lee J; Jung J; Kim GH; Yun CY; Jung SH; Hwang BY; Hong JT; Han SB; Jung JK; Kim Y
Int J Biol Sci; 2024; 20(5):1688-1704. PubMed ID: 38481807
[No Abstract] [Full Text] [Related]
10. Manassantin A inhibits cAMP-induced melanin production by down-regulating the gene expressions of MITF and tyrosinase in melanocytes.
Lee HD; Lee WH; Roh E; Seo CS; Son JK; Lee SH; Hwang BY; Jung SH; Han SB; Kim Y
Exp Dermatol; 2011 Sep; 20(9):761-3. PubMed ID: 21569106
[TBL] [Abstract][Full Text] [Related]
11. Melanogenic Effects of Maclurin Are Mediated through the Activation of cAMP/PKA/CREB and p38 MAPK/CREB Signaling Pathways.
Hwang YS; Oh SW; Park SH; Lee J; Yoo JA; Kwon K; Park SJ; Kim J; Yu E; Cho JY; Lee J
Oxid Med Cell Longev; 2019; 2019():9827519. PubMed ID: 31949887
[TBL] [Abstract][Full Text] [Related]
12. p44/42 MAPK signaling is a prime target activated by phenylethyl resorcinol in its anti-melanogenic action.
Kang M; Park SH; Park SJ; Oh SW; Yoo JA; Kwon K; Kim J; Yu E; Cho JY; Lee J
Phytomedicine; 2019 May; 58():152877. PubMed ID: 30849679
[TBL] [Abstract][Full Text] [Related]
13. Diethylstilbestrol enhances melanogenesis via cAMP-PKA-mediating up-regulation of tyrosinase and MITF in mouse B16 melanoma cells.
Jian D; Jiang D; Su J; Chen W; Hu X; Kuang Y; Xie H; Li J; Chen X
Steroids; 2011 Nov; 76(12):1297-304. PubMed ID: 21745488
[TBL] [Abstract][Full Text] [Related]
14. Tribuloside acts on the PDE/cAMP/PKA pathway to enhance melanogenesis, melanocyte dendricity and melanosome transport.
Cao Y; Lv J; Tan Y; Chen R; Jiang X; Meng D; Zou K; Pan M; Tang L
J Ethnopharmacol; 2024 Apr; 323():117673. PubMed ID: 38158096
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol promotes production of melanin by activating the microphthalmia-associated transcription factor (MITF).
Wei B; Zhang YP; Yan HZ; Xu Y; Du TM
Biochem Biophys Res Commun; 2014 Jan; 443(2):617-21. PubMed ID: 24333333
[TBL] [Abstract][Full Text] [Related]
16. Depigmenting action of platycodin D depends on the cAMP/Rho-dependent signalling pathway.
Jung E; Hwang W; Kim S; Kim YS; Kim YS; Lee J; Park D
Exp Dermatol; 2011 Dec; 20(12):986-91. PubMed ID: 21995379
[TBL] [Abstract][Full Text] [Related]
17. Fargesin inhibits melanin synthesis in murine malignant and immortalized melanocytes by regulating PKA/CREB and P38/MAPK signaling pathways.
Fu T; Chai B; Shi Y; Dang Y; Ye X
J Dermatol Sci; 2019 Apr; 94(1):213-219. PubMed ID: 30956031
[TBL] [Abstract][Full Text] [Related]
18. G protein-coupled estrogen receptor enhances melanogenesis via cAMP-protein kinase (PKA) by upregulating microphthalmia-related transcription factor-tyrosinase in melanoma.
Sun M; Xie HF; Tang Y; Lin SQ; Li JM; Sun SN; Hu XL; Huang YX; Shi W; Jian D
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):236-246. PubMed ID: 27378491
[TBL] [Abstract][Full Text] [Related]
19. Involvement of adenylate cyclase/cAMP/CREB and SOX9/MITF in melanogenesis to prevent vitiligo.
Arora N; Siddiqui EM; Mehan S
Mol Cell Biochem; 2021 Mar; 476(3):1401-1409. PubMed ID: 33389492
[TBL] [Abstract][Full Text] [Related]
20. Diazepam enhances melanogenesis, melanocyte dendricity and melanosome transport via the PBR/cAMP/PKA pathway.
Lv J; Fu Y; Gao R; Li J; Kang M; Song G; Yun C
Int J Biochem Cell Biol; 2019 Nov; 116():105620. PubMed ID: 31561018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
